In a novel interpretation of the Federal Trade Commission (FTC) Act, the U.S. District Court for the District of Delaware recently held in FTC v. Shire ViroPharma that the FTC had failed to plead the facts necessary to invoke...more
5/29/2018
/ Anti-Competitive ,
Antitrust Litigation ,
Citizen Petitions ,
Corporate Counsel ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
FTC Act ,
Generic Drugs ,
Leave to Amend ,
Permanent Injunctions ,
Pharmaceutical Industry